Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
dexamethasonnatriumphosphat 5 mg/ml injektionsvæske, opløsning, hætteglas a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Some |
|
Dexamethasone sodium phosphate [musculoskeletal use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Some |
|
dexamethasonnatriumphosphat 5 mg/ml injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Some |
|
dexamethasonnatriumphosphat 0,1 % øjendråber til engangsbrug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Some |
|
Dexamethasone sodium phospha 4mg/mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Some |
|
dexamethasonnatriumphosphat 0,1 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Some |
|
Dexamethasone sodium phospha 0.05% |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Some |
|
Dexamethasone phosphate + dexamethasone sodium phospha 1mg/0ns solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Some |
|
dexamethasonnatriumphosphat + lidocainhydrochlorid 4 mg/10 mg/ml injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Some |
|
Dexamethasone sodium phospha + neomycin sulfate 0ns/0ns solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Some |
|
dexamethasonnatriumphosphat 1 mg +neomycinsulfat 3,5 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Some |
|
dexamethasonnatriumphosphat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Some |
|
dexamethason 1 mg + neomycinsulfat 3,5 mg salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Some |
|
dexamethasonnatriumphosphat +neomycinsulfat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Some |
|
dexamethasonnatriumphosphat 0,5 %, øjendråber til engangsbrug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Some |
|
dexamethasonnatriumphosphat 0,1 mg/ml opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Some |
|
dexamethasonnatriumphosphat 24 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Some |
|
dexamethasonnatriumphosphat 10 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Some |
|
dexamethasonnatriumphosphat 4 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Some |
|
Dexamethasone sodium phosphate 0.05% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Some |
|
Dexamethasone sodium phosphate 0.1% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Some |
|
Product containing precisely dexamethasone (as dexamethasone sodium phosphate) 400 microgram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely dexamethasone phosphate (as dexamethasone sodium phosphate) 4 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely dexamethasone (as dexamethasone sodium phosphate) 1 milligram/1 milliliter and ofloxacin 3 milligram/1 milliliter conventional release eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely dexamethasone phosphate (as dexamethasone sodium phosphate) 1 milligram/1 milliliter conventional release eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely dexamethasone phosphate (as dexamethasone sodium phosphate) 1 milligram/1 milliliter and tobramycin (as tobramycin sulfate) 3 milligram/1 milliliter conventional release eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely chloramphenicol 10 milligram/1 milliliter and dexamethasone sodium phosphate 1 milligram/1 milliliter conventional release ear and eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely chloramphenicol 10 milligram/1 milliliter and dexamethasone sodium phosphate 1 milligram/1 milliliter conventional release ear and eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Some |
2 |
Dexamethasone phosphate (as dexamethasone sodium phosphate) 4 mg/mL solution for infusion |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Some |
1 |
Dexamethasone phosphate (as dexamethasone sodium phosphate) 4 mg/mL solution for infusion and/or injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely dexamethasone (as dexamethasone sodium phosphate) 1 milligram/1 milliliter and levofloxacin 5 milligram/1 milliliter conventional release solution for eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Dexamethasone sodium phosphate (substance) |
Inferred relationship |
Some |
2 |